Leon Cornelius Snyman

Prof. Leon Cornelius Snyman


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2013 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
LDLynette Denny
Lynette Denny
IAIsaac Adewole
Isaac Adewole
RARose Anorlu
Rose Anorlu
GDGreta Dreyer
Greta Dreyer
MMManivasan Moodley
Manivasan Moodley
JSJohannes Schmidt
Johannes Schmidt

28 November 2014 in South African Medical Journal
Verified
Journal Article
Open access
PDF file
MBMatthys H. Botha
Matthys H. Botha
FMFrederick Haynes Van der Merwe
Frederick Haynes Van der Merwe
LSLeon Cornelius Snyman
Leon Cornelius Snyman
GDGreta Dreyer
Greta Dreyer
The Vaccine and Cervical Cancer Screen (VACCS) project: Acceptance of human papillomavirus vaccination in a school-based programme in two provinces of South Africa

9 October 2015 in South African Medical Journal
Verified
Journal Article
Open access
PDF file
GDGreta Dreyer
Greta Dreyer
FMFrederick H Van der Merwe
Frederick H Van der Merwe
MBMatthys H. Botha
Matthys H. Botha
LSLeon Cornelius Snyman
Leon Cornelius Snyman
DCDeborah Constant
Deborah Constant
JHJustin Harvey
Justin Harvey
School-based human papillomavirus vaccination: An opportunity to increase knowledge about cervical cancer and improve uptake of screening

6 January 2015 in South African Medical Journal
Verified
Journal Article
Open access
PDF file
LSLeon Cornelius Snyman
Leon Cornelius Snyman
GDGreta Dreyer
Greta Dreyer
MBMatthys H. Botha
Matthys H. Botha
HMHaynes Van Der Merwe
Haynes Van Der Merwe
PBPiet J Becker
Piet J Becker
The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa

29 April 2020 in Cancers
Verified
Journal Article
Open access
PDF file
KNKristyna Nemejcova
Kristyna Nemejcova
RKRoman Kocian
Roman Kocian
Christhardt KohlerChristhardt Kohler
Christhardt Kohler
JJJiri Jarkovsky
Jiri Jarkovsky
JKJaroslav Klát
Jaroslav Klát
DCDavid Cibula
David Cibula
The quality of pathological assessment is crucial for the safety of patients with cervical cancer if pelvic lymph node dissection is to be replaced by sentinel lymph node (SLN) biopsy. Central pathology review of SLN pathological ultrastaging was conducted in the prospective SENTIX/European Network of Gynaecological Oncological Trial (ENGOT)-CX2 study. All specimens from at least two patients per site were submitted for the central review. For cases with major or critical deviations, the sites were requested to submit all samples from all additional patients for second-round assessment. From the group of 300 patients, samples from 83 cases from 37 sites were reviewed in the first round. Minor, major, critical, and no deviations were identified in 28%, 19%, 14%, and 39% of cases, respectively. Samples from 26 patients were submitted for the second-round review, with only two major deviations found. In conclusion, a high rate of major or critical deviations was identified in the first round of the central pathology review (28% of samples). This reflects a substantial heterogeneity in current practice, despite trial protocol requirements. The importance of the central review conducted prospectively at the early phase of the trial is demonstrated by a substantial improvement of SLN ultrastaging quality in the second-round review.

9 April 2005 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
GDG. Dreyer
G. Dreyer
LSLeon Cornelius Snyman
Leon Cornelius Snyman
AMA. Mouton
A. Mouton
BLB.G. Lindeque
B.G. Lindeque